Measles, mumps, rubella – (MMR)
Recommended Age Range:
12–15 months and 4–6 years
Common Side Effects:
Fever, rash, swelling of glands
Research & Testing History:
Licensed 1971; multiple decades of post-market surveillance
Use History:
Routine use since 1971
Trial Size:
30+ double-blind controlled trials, Large-scale pre- and post-market
Years on Schedule:
~54 years
Known Safety Concerns:
Rare febrile seizures
Ingredients:
- MMR II: Live attenuated measles, mumps, and rubella viruses; stabilizers: sorbitol, sucrose, hydrolyzed gelatin; residuals: proteins from WI-38 human cells, recombinant human albumin, fetal bovine serum, neomycin
- Priorix: Live attenuated measles, mumps, and rubella viruses; stabilizers: anhydrous lactose, sorbitol, amino acids, mannitol; residuals: proteins from MRC-5 human cells, neomycin sulphate, ovalbumin, bovine serum albumin